Popular topics to explore
NETWEB Stocks up more than +100% in last 1 year:
Swan Defence: +978%
Cupid: +852%
Sterlite Tech.: +518%
Sigma Advanced System: +515%
Modern Insulator: +462%
V-Marc India: +445%
MTAR Technologie: +388%
Midwest Gold: +387%
CIAN Agro: +337…
BLISSGVS
Bliss GVS Pharma are likely to remain in focus on June 3 after the company announced that it has received an Inspection Closure Report from the World Health Organization (WHO), Geneva, for its manufacturing facility in Palghar, Maharashtra.…
BLISSGVS
Bliss GVS Pharma Limited is undergoing a major ownership transition, as Anupam Rasayan India Limited has moved to acquire a controlling stake. Anupam Rasayan has signed an agreement to purchase 43.30% of Bliss GVS from existing promoters an…
Anupam Rasayan Expands Pharma Presence With ₹1,369 Crore Bliss GVS Deal
ANURAS will acquire up to a 43% stake in Bliss GVS Pharma for around ₹1,369 crore. The acquisition marks a major diversification step for Anupam Rasayan, which has primarily operated in specialty chemicals and custom synthesis.
The deal s…
Anupam Rasayan to Acquire 74.20% Stake in Bliss GVS Pharma for ~₹2,199 Crore
Anupam Rasayan India Ltd has approved the acquisition of up to 74.20% equity and control in Bliss GVS Pharma Limited at ₹299 per share, representing a total consideration of approximately ₹2,199 crore. Transaction Structure: Phase 1: Acqu…
7th Apr · SEBI-Registered Analyst
Currency Grow (CA & SEBI Reg IA Omkar Bhutada) · 7th Apr
Multi-Year Breakout After Long Consolidation – Structural Bull Run Ahead?
BLISSGVS
The chart reflects a massive multi-year consolidation breakout above ₹210–₹220, marking a significant structural shift from range-bound movement to a potential long-term uptrend.
From an Elliott Wave perspective, the prolonged…
MCX Outperformers in a Weak Market: High Relative Strength Stocks 🚀
- PARKHOSPS
- BLISSGVS
- PFOCUS
- INDSWFTLAB
- ACUTAAS
- ATLANTAELE
- AEROFLEX
- TORNTPHARM
- POWERINDIA
- GRANULES
- SMSPHARMA
- MCX
- PRIVISCL
- CENTUM
Bliss GVS Pharma – Breakout Retest with Fresh Momentum (Daily)
BLISSGVS is showing a strong bullish structure after a steady uptrend, with price currently holding above key breakout zones and resuming upward momentum.
Technical Structure
The stock has moved through a classic accumulation → breakout…
Watchlist for this Week
Keep these stocks on radar, strong setups forming this week 👇 Retesting Breakout Zones • Data Patterns • GE T&D India • Karnataka Bank • Apex Frozen Foods • BLISSGVS • TD Power Systems Healthy retests = potential continuation moves St…
Bliss GVS Pharma Ltd – Channel Top Revisited Amid Bearish RSI Divergence
BLISSGVS
📍 Price Structure
The stock remains confined within a rising parallel channel, now testing the upper boundary near ₹182. Volume has surged notably in recent weeks, signaling heightened market activity near this critical resistan…
Bliss GVS Pharma Ltd (BLISSGVS) – SWOT Analysis
BLISSGVS
Strengths
Specialised Pharmaceutical Player: Focus on suppositories, pessaries, oral solids, and liquid formulations.
Strong Export Orientation: Significant presence in Africa, CIS, and Latin America.
WHO-GMP Approved Faciliti…
4th Dec · SEBI-Registered Analyst
Investment Insights with Adarsh · 4th Dec
Bliss GVS Pharma Ltd — Fundamental Overview
BLISSGVS
Bliss GVS Pharma Ltd is a pharmaceutical company that develops, manufactures, and markets a variety of generic drugs, active pharmaceutical ingredients (APIs), and contract manufacturing services. The company serves both domestic…
Stocks in news today
APOLLO (AMS) has entered into Joint Development Memorandum of Understanding (MoU) with the Indian Navy represented by Directorate General of Naval Armament Inspection (DGNAI), and the Indian Institute of Technology, Chennai (IIT-Chennai).…
📌 Follow-Up Update: Bliss GVS Pharma – Momentum Re-Ignited
Price: ₹172
View: Bullish follow-up
🔍 What’s happening now?
BLISSGVS has delivered a strong follow-through move after last week’s breakout recovery. Price reclaimed the ₹170 zone with solid volume support, showing buyers are firmly defe…
Bliss GVS Pharma — “Breakout Build-Up With Smart Money Flow”
BLISSGVS (₹171)
The stock is consolidating tightly near ₹170–175 after a sharp recovery from the October dip. Volume expansion + a strong OBV surge to 253M signals institutional accumulation. Price is trending above the 20-EMA, showing su…
10th Nov · SEBI-Registered Analyst
Investment Insights with Adarsh · 10th Nov
Bliss GVS Pharma Ltd — Stock Report
BLISSGVS
Bliss GVS Pharma Ltd is an Indian pharmaceutical company established in 1984, now specialising in a broad range of formulations including tablets, capsules, syrups, injections, and notably suppositories and pessaries—where it cla…
Keep an Eye-
Key Positives Infosys – Sets November 14 as record date for its ₹18,000 crore share buyback. Time Technoplast – Launches ₹800 crore QIP (8.8% equity dilution) at ₹201.12, a 3.8% discount to CMP. RITES – Signs agreement with the Director…
BNP Paribas Buys 1.9% Stake in RBL Bank for ₹377 Crore; Stock Jumps 9% After ENBD Acquisition Plans
BNP Paribas Financial Markets has acquired a 1.9% equity stake in RBL Bank through open market transactions worth ₹377 crore on October 20. The global financial firm bought 1.18 crore shares of the private lender at an average price of ₹317…
Chemical Stocks continue to outperform the market
In the last 11 months, the chemicals and petrochemicals sector has been a top destination for foreign portfolio investment (FPI) in Indian equities. It is the only sector to see uninterrupted FPI inflows, including $130 million in July and…
15th Dec 2024 · SEBI-Registered Analyst
Market Beast by Vibhu Jain (SEBI RA) · 15th Dec 2024
Bliss GVS Pharma
Bliss GVS Pharma, a smallcap pharmaceutical company, has recently hit a 52-week high with its stock price reaching Rs.179.65 on December 13, 2024. The stock has been performing well in the market, outperforming its sector by 3.64% on the sa…
